Toxicity of drug abuse — amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use
- 15 March 2000
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 112-113, 147-152
- https://doi.org/10.1016/s0378-4274(99)00217-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Low-dose MDMA (“ecstasy”) induces vasopressin secretionThe Lancet, 1998
- Drugged driving, a review based on the experience in NorwayDrug and Alcohol Dependence, 1997
- Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): Apropos of a fatal accident during car-surfingInternational journal of legal medicine, 1994
- Ecstasy and Whizz at a rave resulting in a major burn plus complicationsBurns, 1993
- Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")The Lancet, 1992
- The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaineEuropean Journal of Pharmacology, 1992
- 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agentsEuropean Journal of Pharmacology, 1990
- 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMAJAMA, 1987
- The Psychological and Physiological Effects of MDMA on Normal VolunteersJournal of Psychoactive Drugs, 1986
- Subjective Reports of the Effects of MDMA in a Clinical SettingJournal of Psychoactive Drugs, 1986